Hossein Javid Selected Research

Neurokinin-1 Receptors (Neurokinin 1 Receptor)

6/2022	The substance P/ neurokinin-1 receptor signaling pathway mediates metastasis in human colorectal SW480 cancer cells.
1/2022	The Therapeutic Potential of Aprepitant in Glioblastoma Cancer Cells through Redox Modification.
1/2021	Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme.
1/2021	Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-κB Signal Transduction Pathways in Colon Cancer Cells.
1/2021	The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells.
6/2020	Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
3/2020	The role of substance P/neurokinin 1 receptor in the pathogenesis of esophageal squamous cell carcinoma through constitutively active PI3K/Akt/NF-κB signal transduction pathways.
11/2019	The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hossein Javid Research Topics

Disease

18	Neoplasms (Cancer) 06/2022 - 01/2018
8	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 05/2020
5	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2021
3	Brain Neoplasms (Brain Tumor) 10/2022 - 01/2021
3	Esophageal Squamous Cell Carcinoma 01/2021 - 03/2020
2	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 01/2021
2	Carcinogenesis 10/2021 - 02/2019
1	Glioma (Gliomas) 01/2022
1	Nausea 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Vomiting 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 06/2020
1	Pathologic Processes 02/2019
1	Atherosclerosis 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

8	Substance PIBA 06/2022 - 11/2019
8	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 06/2022 - 11/2019
6	Aprepitant (Emend)FDA Link 06/2022 - 06/2020
3	resazurinIBA 06/2022 - 01/2021
3	MicroRNAs (MicroRNA)IBA 01/2022 - 02/2019
2	CaspasesIBA 01/2022 - 01/2021
2	PhytochemicalsIBA 01/2021 - 05/2020
2	TachykininsIBA 01/2021 - 06/2020
2	Peptides (Polypeptides)IBA 01/2021 - 03/2020
1	GelatinIBA 06/2022
1	AlkaloidsIBA 01/2022
1	isoquinolineIBA 01/2022
1	AntioxidantsIBA 01/2022
1	BerberineIBA 01/2022
1	CytokinesIBA 10/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Superoxide DismutaseIBA 01/2021
1	CatalaseIBA 01/2021
1	Annexin A5IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	DiarylheptanoidsIBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	antiglomerular basement membrane antibodyIBA 01/2021
1	NeuropeptidesIBA 06/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2020
1	Tachykinin Receptors (Tachykinin Receptor)IBA 06/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2020
1	QuercetinIBA 05/2020
1	ThioredoxinsIBA 11/2019
1	MTOR InhibitorsIBA 02/2019
1	TOR Serine-Threonine KinasesIBA 02/2019
1	Proteins (Proteins, Gene)FDA Link 02/2019
1	Protein Kinases (Protein Kinase)IBA 02/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 02/2019
1	CurcuminIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2018
1	Progesterone FDA LinkGeneric 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Hormones (Hormone)IBA 01/2018
1	ParaffinIBA 01/2018

Therapy/Procedure

7	Therapeutics 01/2022 - 11/2019
4	Drug Therapy (Chemotherapy) 01/2022 - 02/2019
2	Radiotherapy 01/2022 - 01/2021
1	Immunotherapy 10/2022